DA
Dover Advisors’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $356K | Sell |
14,690
-7,943
| -35% | -$193K | 0.16% | 115 |
|
2025
Q1 | $574K | Buy |
22,633
+8,824
| +64% | +$224K | 0.25% | 89 |
|
2024
Q4 | $366K | Sell |
13,809
-968
| -7% | -$25.7K | 0.21% | 96 |
|
2024
Q3 | $428K | Sell |
14,777
-1,165
| -7% | -$33.7K | 0.24% | 89 |
|
2024
Q2 | $446K | Sell |
15,942
-6,617
| -29% | -$185K | 0.28% | 87 |
|
2024
Q1 | $626K | Buy |
22,559
+7,454
| +49% | +$207K | 0.43% | 70 |
|
2023
Q4 | $435K | Sell |
15,105
-5,876
| -28% | -$169K | 0.57% | 58 |
|
2023
Q3 | $696K | Sell |
20,981
-43
| -0.2% | -$1.43K | 0.7% | 51 |
|
2023
Q2 | $771K | Sell |
21,024
-1,688
| -7% | -$61.9K | 0.68% | 50 |
|
2023
Q1 | $927K | Buy |
22,712
+2,540
| +13% | +$104K | 0.89% | 36 |
|
2022
Q4 | $1.03M | Buy |
+20,172
| New | +$1.03M | 1.11% | 29 |
|